Flowens Prostate – Health Canada Product Monograph


Health Canada Product Monograph – Flowens

Dose(s), recommended uses, duration of use, risk statements according to the nomenclature of

Health Canada

Natural Product Number (NPN):


Current status:


Brand name(s):




Dosage form:


Recommended route of administration:


Recommended dose:
Subpopulation (Sub-pop.) Quantity (Qty) Frequency (Freq.)
Sub-pop. Age Min. Max. UDM Note1


Qty Min. Max. UDM Qty Freq. Min. Max. UDM Fréq.

Note 1

UDM: unit of measurement


Adult males 1.0 Capsule 2 Every day
Adult males 1.0 Capsule 1 2 Every day

Recommended Uses or Purposes:

  • Helps improve international prostate symptom scores.
  • Helps reduce urinary symptoms in men over the age of 45 with benign prostatic hyperplasia (BPH).
  • Helps support normal urinary function.
  • Helps improve lower urinary tract symptoms.
  • Helps maintain normal urinary function and urinary storage in men over the age of 45 with lower urinary tract symptoms (STU).
  • Helps relieve urological symptoms (e.g., low urine flow, incomplete mucous membrane, frequent urination during the day and night) associated with benign prostatic hyperplasia (BPH).

Risk Information:

Precautions and warnings:

Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you have a history of kidney stones.


List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Activity
Vaccinium macrocarpon 250.0 milligram

List of non-medicinal ingredients:

Hydroxypropyl methylcellulose

  • Hydroxypropyl methylcellulose

Date of approval:


Date of licence amendment:

You cannot copy content of this page